American Heart Association (AHA)
7272 Greenville Avenue
607 articles with American Heart Association (AHA)
The American Heart Association's 2021 Paul "Bear" Bryant Heart of a Champion Award honors a college football coach for outstanding accomplishments both on and off the field
33 Organizations Representing Millions of Patients Urge Policymakers to Adopt "Patient-First" Policy Agenda
A coalition of 33 organizations representing millions of people with pre-existing conditions launched an unprecedented effort by releasing their top priorities for the next Administration.
The American Heart Association and KLA Foundation create $1.5 million Social Equity Fund for COVID-19 relief in California and Michigan
Fund seeks applications from local non-profits in affected communities in Silicon Valley, South Bay and Detroit metro area
Eight Genesis HealthCare Facilities Receive New American Heart Association Post-Acute Care Heart Failure Center Certification
As part of an effort to reduce avoidable hospital readmissions along with gaps in care coordination both within and across settings, and to improve outcomes for patients, the American Heart Association has awarded the first Post-Acute Care Heart Failure Center Certification to eight Genesis HealthCare skilled nursing facilities.
Ride Health CEO Imran Cronk to Present at South by Southwest Alongside Leaders from American Heart Association and Ascension
Company also exhibiting cloud-based transportation coordination platform at RISE Medicare Advantage Summit and AMGA Annual Conference
The American Heart Association's Go Red for Women® movement invites you to wear red with heart-health advocates nationwide demanding better care, greater inclusion of women in research
Screenings available on select Thursdays in February at MinuteClinic locations nationwide
The American Heart Association ("AHA") Recognizes Mezzion's FUEL Trial as the Biggest Victory in Congenital Heart Disease ("CHD") Advancements for 2019
The National Heart, Lung, and Blood Institute also Recognizes the FUEL Trial as an Advancement in CHD for 2019
Portola Pharmaceuticals to Support New American Heart Association Initiative to Address Hemorrhagic Stroke
American Heart Association Quality Improvement Project Promotes Patient Education and Physician Best Practices for Hemorrhagic Stroke
Patrick Magoon To Receive American Heart Association's Prestigious Heart Of Gold Award At 2020 Chicago Heart Ball
Patrick Magoon, outgoing president and chief executive officer at Ann & Robert H. Lurie Children's Hospital of Chicago, will receive the American Heart Association's prestigious Heart of Gold Award at the Chicago Heart Ball on Saturday, April 4.
This fundraising achievement makes Perspecta the largest, single-year fundraising company in history for the Greater Washington Heart Walk, two years in row, breaking its previous record of $310,000.
Bayer Announces National Sponsorship of the American Heart Association and the American Diabetes Association's Know Diabetes by Heart initiative
Bayer announced it has joined Know Diabetes by Heart™, a joint initiative of the American Heart Association and the American Diabetes Association, as a national sponsor.
Liminal Presents New Preclinical Data on PBI-4050 and its Effect on Angio-Proliferative Pulmonary Arterial Hypertension
Liminal BioSciences Inc. announced the presentation of two scientific posters with new preclinical data for PBI-4050 and the treatment of pulmonary arterial hypertension at the American Heart Association 2019 conference taking place on November 16-18, 2019 in Philadelphia, PA..
Endotronix Announces Positive Data from the SIRONA First-in-Human Trial for the Cordella™ PA Pressure Sensor System
Data presented at the 2019 American Heart Association Scientific Sessions
Interim analysis from EMPRISE real-world study shows Jardiance® decreased risk of hospitalization for heart failure compared with DPP-4 inhibitors and GLP-1 receptor agonists
This analysis on effectiveness also shows Jardiance® (empagliflozin) was associated with a similar risk of non-fatal atherosclerotic cardiovascular events compared with DPP-4 inhibitors or GLP-1 receptor agonists
ISCHEMIA-CKD Trial: Advanced Chronic Kidney Disease Patients Treated with Invasive Heart Procedures Show No Reduction in Rate of Cardiac Events
Heart disease is the leading cause of death for the roughly 500 million people worldwide with chronic kidney disease Yet such patients have been excluded from most of the major, relevant cardiovascular clinical trials that are meant to guide treatment approaches for them.
Kiniksa Presents Rilonacept Final Phase 2 Clinical Data at the American Heart Association Scientific Sessions 2019
Rapid resolution of both reported pain and inflammation as well as improvement in quality of life scores
Mezzion Pharma announces Top Line Data from FUEL will be presented at the American Heart Association (AHA), Late Breaking Scientific Sessions, in Philadelphia, PA, November 17, 2019
Mezzion Pharma Co. Ltd. announces that on Sunday, November 17, 2019, at 10:45 am EST, Dr. David Goldberg, Children's Hospital of Philadelphia, will present the results of Mezzion's landmark FUEL Phase 3 Clinical Trial.
MyoKardia Announces Abstracts Selected for Presentation at the American Heart Association Scientific Sessions 2019Company to Host Conference Call and Webcast on November 11, 2019 at 8:30 a.m. ET (5:30 a.m. PT)
The abstracts include new data from the ongoing PIONEER open-label extension (PIONEER-OLE) study of mavacamten, preclinical studies of mavacamten and MYK-491, and hypertrophic cardiomyopathy (HCM) population insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
Imonti is passionate about supporting the organization's mission to add years of health and well-being to the lives of all Americans.